Skip to content
video episode
0:00 / 23:56
Peptides Explained · September 7 · 23 min

GLP-1 Microdosing: Smart Strategy or the Next Wellness Fad?

Visit peptidesexplained.info for more info and resources For more info on research peptides check out PeptidesExplained.info/OfflinePeptides or email John at john@peptidesexplained.info What exactly is GLP-1 microdosing? Depending on who you ask, it can mean remaining on the starter dose, taking a fraction of that dose, spacing injections farther apart, stepping down after weight loss, or using a tiny amount for food noise and longevity. Those are not the same strategy. John Garrett breaks down the new low-dose semaglutide and tirzepatide data, FDA-approved dose structures, weight-regain research, maintenance questions, side effects, and the major gap between individualized clinical titration and social-media "microdosing" protocols. Educational content only. Not medical advice.

transcript

No transcript — this publisher did not publish one.

show notes

Visit peptidesexplained.info for more info and resources

For more info on research peptides check out PeptidesExplained.info/OfflinePeptides or email John at john@peptidesexplained.info

What exactly is GLP-1 microdosing?

Depending on who you ask, it can mean remaining on the starter dose, taking a fraction of that dose, spacing injections farther apart, stepping down after weight loss, or using a tiny amount for food noise and longevity.

Those are not the same strategy.

John Garrett breaks down the new low-dose semaglutide and tirzepatide data, FDA-approved dose structures, weight-regain research, maintenance questions, side effects, and the major gap between individualized clinical titration and social-media "microdosing" protocols.

Educational content only. Not medical advice.